World Health Organization starts vaccination campaign in Iraq; Daiichi Sankyo recalls 8 vaccine lots;

> In an effort to contain a major cholera outbreak in Iraq, the World Health Organization has kick-started a campaign to vaccinate 255,000 people there against the illness within a month. Report

> Daiichi Sankyo recalled two lots of a freeze-dried live attenuated measles vaccine and 6 lots of a measles and rubella combined vaccine. Report

> TapImmune relocated its corporate headquarters from Seattle to Jacksonville, FL, to prepare for Phase II breast cancer vaccine trials next year in conjunction with the Mayo Clinic in Florida. Report

> Research published in The Journal of Infectious Diseases this week suggested that statins could negatively impact the protective qualities of flu vaccines. Report

> Saint Louis University received a $5.8 million National Institutes of Health contract for an "omics" research initiative into the safety and effectiveness of vaccines and other methods to combat infectious diseases. Release

Suggested Articles

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.